Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Smith and Nephew Plc New SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image...


NYSE:SNN - Post by User

Comment by radcaton Oct 30, 2022 10:07am
89 Views
Post# 35058441

RE:Div makes this attractive

RE:Div makes this attractiveI am a new shareholder. Bought my shares a few days before the Sept 29th, the ex-dividend date. What I liked about SNN was...
Covid-19 was made public on Jan 25th 2020, SNN share price on Jan 26th 2020 closed at $50.57. The high for the past year Nov 5th 2021 was $37.15. Both past share prices make SNN + dividend seem like a bargain. We all saw our hospitals over capacity with ill covid patients, while others who needed surgery, hips and knees for example, were delayed indefinitely. Brexit, Covid-19, and British Parliament shenanigans have also contributed negatively to the share price. Going forward Smith & Nephew should see their business take a turn for the better providing we do not see a repeat of Covid. Will buy more shares when I can.   
<< Previous
Bullboard Posts
Next >>